BIOSITE INC 4

Accession 0001238916-07-000004

CIK 0000834306operating

View on SEC.gov Company Profile

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 5:35 PM ET

Size

40.2 KB

Accession

0001238916-07-000004

Insider Transaction Report

Form 4

Period: 2007-06-29

BIOSITE INCBSTE

BUECHLER KENNETH F

President & Chief Scientific OOther

Transactions

Disposition from Tender
Common Stock
2007-06-29$92.50/sh−58$5,365→ 0 total
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−2,406→ 0 total
Exercise: $41.56Exp: 2011-06-14→ Common Stock (2,406 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−10→ 0 total
Exercise: $13.88Exp: 2008-05-21→ Common Stock (10 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−4,008→ 0 total
Exercise: $24.95Exp: 2012-06-18→ Common Stock (4,008 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−3,726→ 0 total
Exercise: $31.63Exp: 2010-06-02→ Common Stock (3,726 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−1,873→ 0 total
Exercise: $53.38Exp: 2015-06-17→ Common Stock (1,873 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−53,127→ 0 total
Exercise: $53.38Exp: 2015-06-17→ Common Stock (53,127 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−2,263→ 0 total
Exercise: $44.18Exp: 2014-06-18→ Common Stock (2,263 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−72,594→ 0 total
Exercise: $41.56Exp: 2011-06-14→ Common Stock (72,594 underlying)
Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−2,098→ 0 total
Exercise: $47.66Exp: 2013-06-18→ Common Stock (2,098 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−32,737→ 0 total
Exercise: $44.18Exp: 2014-06-18→ Common Stock (32,737 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−15,000→ 0 total
Exercise: $49.15Exp: 2014-10-22→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−23,878→ 0 total
Exercise: $24.95Exp: 2012-06-18→ Common Stock (23,878 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−71,274→ 0 total
Exercise: $31.63Exp: 2010-06-02→ Common Stock (71,274 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−77,902→ 0 total
Exercise: $47.66Exp: 2013-06-18→ Common Stock (77,902 underlying)

Footnotes (14)

[F1]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $786 representing the difference between the exercise price of the option and $92.50, the merger consideration ($78.63 per share).
[F10]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $3,697,938 representing the difference between the exercise price of the option and $92.50, the merger consideration ($50.94 per share).
[F11]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $1,581,852 representing the difference between the exercise price of the option and $92.50, the merger consideration ($39.12 per share).
[F12]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $3,493,126 representing the difference between the exercise price of the option and $92.50, the merger consideration ($44.84 per share).
[F13]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $650,250 representing the difference between the exercise price of the option and $92.50, the merger consideration ($43.35 per share).
[F14]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $2,078,328 representing the difference between the exercise price of the option and $92.50, the merger consideration ($39.12 per share).
[F2]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $270,740 representing the difference between the exercise price of the option and $92.50, the merger consideration ($67.55 per share).
[F3]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $226,820 representing the difference between the exercise price of the option and $92.50, the merger consideration ($60.88 per share).
[F4]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $122,562 representing the difference between the exercise price of the option and $92.50, the merger consideration ($50.94 per share).
[F5]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $109,348 representing the difference between the exercise price of the option and $92.50, the merger consideration ($48.32 per share).
[F6]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $94,074 representing the difference between the exercise price of the option and $92.50, the merger consideration ($44.84 per share).
[F7]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $73,272 representing the difference between the exercise price of the option and $92.50, the merger consideration ($39.12 per share).
[F8]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $1,606,204representing the difference between the exercise price of the option and $92.50, the merger consideration ($67.55 per share).
[F9]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was canceled by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness in exchange for a cash payment of $4,338,805 representing the difference between the exercise price of the option and $92.50, the merger consideration ($60.88 per share).

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOSITE INC

CIK 0000834306

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000834306

Filing Metadata

Form type: 4
Filed: Jul 1, 8:00 PM ET
Accepted: Jul 2, 5:35 PM ET
Size: 40.2 KB

View on SEC.gov